Has Roshan Patel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $31,365 in general payments to Roshan Patel, MD across 52 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Roshan Patel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Roshan Patel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Roshan Patel, MD

Urology · Orange, CANPI 1760774491

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (46.2%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Cook Incorporated at 46.4% of the total. Among urology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$31,365in general payments, 2019–2025

Across 52 payments — averaging $603.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Cook Incorporated$15K
Johnson & Johnson$5K
Alnylam Pharmaceuticals Inc.$5K
Novo Nordisk$2K
Vascular Technology, Inc.$2K
Cook Medical LLC$750
plus $2K from 10 others

$74,308in research payments, 2019–2025

Across 4 payments — averaging $18,577 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Cook Research Incorporated$74K

What the payments were for

Consulting fees$14,48746%
Speaking & faculty fees$13,61043%
Travel & lodging$1,0423%
Food & beverage$2,2267%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Cook Incorporated	6	$14,540
Johnson & Johnson	10	$5,344
Alnylam Pharmaceuticals Inc.	1	$4,770
Novo Nordisk	4	$2,437
Vascular Technology, Inc.	2	$1,800
Cook Medical LLC	9	$750
Coloplast	2	$521
Calyxo, Inc.	4	$272
Boston Scientific	4	$206
C. R. Bard, Inc. & Subsidiaries	2	$170
KARL Storz Endoscopy-america	2	$152
Conmed Corporation	1	$147
Mallinckrodt Hospital Products Inc.	2	$144
Pharmaand GmbH	1	$39
Tolmar, Inc.	1	$39
Sumitomo Pharma America, Inc.	1	$33

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,365 in reported general payments places this provider in the 90th percentile of 1,324 urology providers in California.

See all urology providers in California →

Medicare billing

Part B allowed, 2024

$201,991

Medicare patients

362

Services billed

1,465

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Potassium Citrate ErPotassium Citrate	107	$7,935
Tamsulosin Hcl	124	$1,567
Cefpodoxime Proxetil	21	$1,002
Chlorthalidone	55	$738
Finasteride	37	$682
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	14	$267
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	19	$135
Ciprofloxacin Hcl	34	$104
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	34	$64
Levofloxacin	12	$19
Diclofenac Sodium	14	$17

Paid to pharmacies, not to this prescriber.

Other urology in Orange

Edward UchioOrange$849K
Jaime LandmanOrange$657K
Ralph ClaymanOrange$523K
Faysal YafiOrange$335K
Bela DenesOrange$235K
Stephen FreedlandWest Hollywood$1.9M
Arie BelldegrunLos Angeles$1.8M
Mihir DesaiLos Angeles$1.5M
Steven WilsonIndio$1.1M
Stuart HoldenLos Angeles$1.1M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →